News & Articles

Detecting lung cancer early with advanced flow cytometry

Our Most Recent News, Events, Press Releases

Latest Information

Latest Updates

bioAffinity Technologies Appoints New Members to Board of Directors

Financial and Clinical Leaders Provide Significant Expertise for the Company’s Commercial Growth  SAN ANTONIO, Texas (August 18, 2025) – bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW), a biotechnology company advancing noninvasive diagnostics for the early detection of lung cancer and other diseases, today announced the appointment of Roberto Rios, CPA, and John J. Oppenheimer, M.D., to its Board of Directors. “Mr. Rios’ business and financial expertise combined with Dr. Oppenheimer’s clinical leadership will be invaluable as we increase sales of CyPath® Lung, develop companion diagnostics for asthma and COPD, and strengthen our financial position,” said Maria Zannes, President and CEO of bioAffinity Technologies. Mr. Rios brings more than four decades of executive leadership in corporate finance and governance across industries...
Read More

bioAffinity Technologies Reports Second Quarter 2025 Results

CyPath® Lung revenues up 62% year-over-year in first six months of 2025   SAN ANTONIO, Texas (August 14, 2025) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on providing noninvasive, accurate...
Full Catalog of Prior Articles, News, Events, and Press Releases

Prior Articles

News & Articles

Precision Pathology laboratory Services

Learn More about

The CyPath® Lung Flow Cytometry Test is sold by Precision Pathology Laboratory Services, a bioAffinity Technologies company,  as a Laboratory Developed Test (LDT).

CyPath® Lung is a non-invasive test that assists clinical decision-making in lung cancer patients whose low-dose computed tomography (LDCT) has demonstrated a suspicious finding.

The test reveals the lung micro-environment by automated analysis of sputum using flow cytometry to characterize cell populations indicative of cancer in the lung.

Physician Portal

Patient Portal

How to Order

CyPath® FAQ

Subscribe for News from bioAffinity Technologies